Chemotherapy Drug Market, Global Outlook and Forecast 2023-2028

Report ID: 1637026 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Chemotherapy Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Chemotherapy Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy Drug Overall Market Size
    2.1 Global Chemotherapy Drug Market Size: 2021 VS 2028
    2.2 Global Chemotherapy Drug Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Chemotherapy Drug Players in Global Market
    3.2 Top Global Chemotherapy Drug Companies Ranked by Revenue
    3.3 Global Chemotherapy Drug Revenue by Companies
    3.4 Top 3 and Top 5 Chemotherapy Drug Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Chemotherapy Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy Drug Players in Global Market
        3.6.1 List of Global Tier 1 Chemotherapy Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Chemotherapy Drug Market Size Markets, 2021 & 2028
        4.1.2 Antimetabolites
        4.1.3 Plant Alkaloids
        4.1.4 Alkylating Agents
        4.1.5 Antitumor Antibiotics
    4.2 By Type - Global Chemotherapy Drug Revenue & Forecasts
        4.2.1 By Type - Global Chemotherapy Drug Revenue, 2017-2022
        4.2.2 By Type - Global Chemotherapy Drug Revenue, 2023-2028
        4.2.3 By Type - Global Chemotherapy Drug Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Chemotherapy Drug Market Size, 2021 & 2028
        5.1.2 Oral
        5.1.3 Intravenous
    5.2 By Application - Global Chemotherapy Drug Revenue & Forecasts
        5.2.1 By Application - Global Chemotherapy Drug Revenue, 2017-2022
        5.2.2 By Application - Global Chemotherapy Drug Revenue, 2023-2028
        5.2.3 By Application - Global Chemotherapy Drug Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Chemotherapy Drug Market Size, 2021 & 2028
    6.2 By Region - Global Chemotherapy Drug Revenue & Forecasts
        6.2.1 By Region - Global Chemotherapy Drug Revenue, 2017-2022
        6.2.2 By Region - Global Chemotherapy Drug Revenue, 2023-2028
        6.2.3 By Region - Global Chemotherapy Drug Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Chemotherapy Drug Revenue, 2017-2028
        6.3.2 US Chemotherapy Drug Market Size, 2017-2028
        6.3.3 Canada Chemotherapy Drug Market Size, 2017-2028
        6.3.4 Mexico Chemotherapy Drug Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Chemotherapy Drug Revenue, 2017-2028
        6.4.2 Germany Chemotherapy Drug Market Size, 2017-2028
        6.4.3 France Chemotherapy Drug Market Size, 2017-2028
        6.4.4 U.K. Chemotherapy Drug Market Size, 2017-2028
        6.4.5 Italy Chemotherapy Drug Market Size, 2017-2028
        6.4.6 Russia Chemotherapy Drug Market Size, 2017-2028
        6.4.7 Nordic Countries Chemotherapy Drug Market Size, 2017-2028
        6.4.8 Benelux Chemotherapy Drug Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Chemotherapy Drug Revenue, 2017-2028
        6.5.2 China Chemotherapy Drug Market Size, 2017-2028
        6.5.3 Japan Chemotherapy Drug Market Size, 2017-2028
        6.5.4 South Korea Chemotherapy Drug Market Size, 2017-2028
        6.5.5 Southeast Asia Chemotherapy Drug Market Size, 2017-2028
        6.5.6 India Chemotherapy Drug Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Chemotherapy Drug Revenue, 2017-2028
        6.6.2 Brazil Chemotherapy Drug Market Size, 2017-2028
        6.6.3 Argentina Chemotherapy Drug Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Chemotherapy Drug Revenue, 2017-2028
        6.7.2 Turkey Chemotherapy Drug Market Size, 2017-2028
        6.7.3 Israel Chemotherapy Drug Market Size, 2017-2028
        6.7.4 Saudi Arabia Chemotherapy Drug Market Size, 2017-2028
        6.7.5 UAE Chemotherapy Drug Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Chemotherapy Drug Major Product Offerings
        7.1.4 Pfizer Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Eli Lilly
        7.2.1 Eli Lilly Corporate Summary
        7.2.2 Eli Lilly Business Overview
        7.2.3 Eli Lilly Chemotherapy Drug Major Product Offerings
        7.2.4 Eli Lilly Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.2.5 Eli Lilly Key News
    7.3 CELGENE
        7.3.1 CELGENE Corporate Summary
        7.3.2 CELGENE Business Overview
        7.3.3 CELGENE Chemotherapy Drug Major Product Offerings
        7.3.4 CELGENE Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.3.5 CELGENE Key News
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Corporate Summary
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Chemotherapy Drug Major Product Offerings
        7.4.4 Bristol-Myers Squibb Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.4.5 Bristol-Myers Squibb Key News
    7.5 Merck
        7.5.1 Merck Corporate Summary
        7.5.2 Merck Business Overview
        7.5.3 Merck Chemotherapy Drug Major Product Offerings
        7.5.4 Merck Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.5.5 Merck Key News
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Corporate Summary
        7.6.2 GlaxoSmithKline Business Overview
        7.6.3 GlaxoSmithKline Chemotherapy Drug Major Product Offerings
        7.6.4 GlaxoSmithKline Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.6.5 GlaxoSmithKline Key News
    7.7 Novartis
        7.7.1 Novartis Corporate Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Chemotherapy Drug Major Product Offerings
        7.7.4 Novartis Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.7.5 Novartis Key News
    7.8 Sanofi
        7.8.1 Sanofi Corporate Summary
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Chemotherapy Drug Major Product Offerings
        7.8.4 Sanofi Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.8.5 Sanofi Key News
    7.9 Teva Pharmaceuticals Industries
        7.9.1 Teva Pharmaceuticals Industries Corporate Summary
        7.9.2 Teva Pharmaceuticals Industries Business Overview
        7.9.3 Teva Pharmaceuticals Industries Chemotherapy Drug Major Product Offerings
        7.9.4 Teva Pharmaceuticals Industries Chemotherapy Drug Revenue in Global Market (2017-2022)
        7.9.5 Teva Pharmaceuticals Industries Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Chemotherapy Drug Market Opportunities & Trends in Global Market
    Table 2. Chemotherapy Drug Market Drivers in Global Market
    Table 3. Chemotherapy Drug Market Restraints in Global Market
    Table 4. Key Players of Chemotherapy Drug in Global Market
    Table 5. Top Chemotherapy Drug Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Chemotherapy Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Chemotherapy Drug Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Chemotherapy Drug Product Type
    Table 9. List of Global Tier 1 Chemotherapy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Chemotherapy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Chemotherapy Drug Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Chemotherapy Drug Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Chemotherapy Drug Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Chemotherapy Drug Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Chemotherapy Drug Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Chemotherapy Drug Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Chemotherapy Drug Product Offerings
    Table 32. Pfizer Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 33. Eli Lilly Corporate Summary
    Table 34. Eli Lilly Chemotherapy Drug Product Offerings
    Table 35. Eli Lilly Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 36. CELGENE Corporate Summary
    Table 37. CELGENE Chemotherapy Drug Product Offerings
    Table 38. CELGENE Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 39. Bristol-Myers Squibb Corporate Summary
    Table 40. Bristol-Myers Squibb Chemotherapy Drug Product Offerings
    Table 41. Bristol-Myers Squibb Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 42. Merck Corporate Summary
    Table 43. Merck Chemotherapy Drug Product Offerings
    Table 44. Merck Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 45. GlaxoSmithKline Corporate Summary
    Table 46. GlaxoSmithKline Chemotherapy Drug Product Offerings
    Table 47. GlaxoSmithKline Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis Corporate Summary
    Table 49. Novartis Chemotherapy Drug Product Offerings
    Table 50. Novartis Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 51. Sanofi Corporate Summary
    Table 52. Sanofi Chemotherapy Drug Product Offerings
    Table 53. Sanofi Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Pharmaceuticals Industries Corporate Summary
    Table 55. Teva Pharmaceuticals Industries Chemotherapy Drug Product Offerings
    Table 56. Teva Pharmaceuticals Industries Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Chemotherapy Drug Segment by Type in 2021
    Figure 2. Chemotherapy Drug Segment by Application in 2021
    Figure 3. Global Chemotherapy Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Chemotherapy Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Chemotherapy Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Chemotherapy Drug Revenue in 2021
    Figure 8. By Type - Global Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 12. US Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 16. Germany Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 17. France Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 24. China Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. India Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 30. Brazil Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Chemotherapy Drug Revenue Market Share, 2017-2028
    Figure 33. Turkey Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Eli Lilly Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. CELGENE Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bristol-Myers Squibb Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Merck Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. GlaxoSmithKline Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sanofi Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Pharmaceuticals Industries Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Chemotherapy Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chemotherapy Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chemotherapy Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports